JP2016537427A - 一酸化炭素を用いた肺疾患の治療または予防 - Google Patents

一酸化炭素を用いた肺疾患の治療または予防 Download PDF

Info

Publication number
JP2016537427A
JP2016537427A JP2016554530A JP2016554530A JP2016537427A JP 2016537427 A JP2016537427 A JP 2016537427A JP 2016554530 A JP2016554530 A JP 2016554530A JP 2016554530 A JP2016554530 A JP 2016554530A JP 2016537427 A JP2016537427 A JP 2016537427A
Authority
JP
Japan
Prior art keywords
concentration
patient
carbon monoxide
gas
hemoglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016554530A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016537427A5 (https=
Inventor
ジェフリー ウェイジャー,
ジェフリー ウェイジャー,
ジョセフ ウェイジャー,
ジョセフ ウェイジャー,
アレックス シュテンツラー,
アレックス シュテンツラー,
Original Assignee
プロテリス, インコーポレイテッド
プロテリス, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プロテリス, インコーポレイテッド, プロテリス, インコーポレイテッド filed Critical プロテリス, インコーポレイテッド
Publication of JP2016537427A publication Critical patent/JP2016537427A/ja
Publication of JP2016537427A5 publication Critical patent/JP2016537427A5/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
JP2016554530A 2013-11-14 2014-11-14 一酸化炭素を用いた肺疾患の治療または予防 Pending JP2016537427A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361904047P 2013-11-14 2013-11-14
US61/904,047 2013-11-14
US201461993137P 2014-05-14 2014-05-14
US61/993,137 2014-05-14
PCT/US2014/065822 WO2015073912A1 (en) 2013-11-14 2014-11-14 Treatment or prevention of pulmonary conditions with carbon monoxide

Publications (2)

Publication Number Publication Date
JP2016537427A true JP2016537427A (ja) 2016-12-01
JP2016537427A5 JP2016537427A5 (https=) 2017-12-28

Family

ID=53058110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016554530A Pending JP2016537427A (ja) 2013-11-14 2014-11-14 一酸化炭素を用いた肺疾患の治療または予防

Country Status (5)

Country Link
US (2) US20160256485A1 (https=)
EP (1) EP3068409A4 (https=)
JP (1) JP2016537427A (https=)
MX (1) MX2016006252A (https=)
WO (1) WO2015073912A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9900177B2 (en) 2013-12-11 2018-02-20 Echostar Technologies International Corporation Maintaining up-to-date home automation models
US9769522B2 (en) 2013-12-16 2017-09-19 Echostar Technologies L.L.C. Methods and systems for location specific operations
TW201618795A (zh) 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
US9824578B2 (en) 2014-09-03 2017-11-21 Echostar Technologies International Corporation Home automation control using context sensitive menus
ES2977455T3 (es) * 2014-09-23 2024-08-23 Shenzhen Seekya Bio Sci & Tech Co Ltd Procedimiento y aparato para medir la concentración de CO endógeno en aire alveolar
US9989507B2 (en) * 2014-09-25 2018-06-05 Echostar Technologies International Corporation Detection and prevention of toxic gas
US9511259B2 (en) 2014-10-30 2016-12-06 Echostar Uk Holdings Limited Fitness overlay and incorporation for home automation system
US9983011B2 (en) 2014-10-30 2018-05-29 Echostar Technologies International Corporation Mapping and facilitating evacuation routes in emergency situations
US9967614B2 (en) 2014-12-29 2018-05-08 Echostar Technologies International Corporation Alert suspension for home automation system
US9729989B2 (en) 2015-03-27 2017-08-08 Echostar Technologies L.L.C. Home automation sound detection and positioning
US9946857B2 (en) 2015-05-12 2018-04-17 Echostar Technologies International Corporation Restricted access for home automation system
US9948477B2 (en) 2015-05-12 2018-04-17 Echostar Technologies International Corporation Home automation weather detection
US9960980B2 (en) 2015-08-21 2018-05-01 Echostar Technologies International Corporation Location monitor and device cloning
US9996066B2 (en) 2015-11-25 2018-06-12 Echostar Technologies International Corporation System and method for HVAC health monitoring using a television receiver
US10101717B2 (en) 2015-12-15 2018-10-16 Echostar Technologies International Corporation Home automation data storage system and methods
US10091017B2 (en) 2015-12-30 2018-10-02 Echostar Technologies International Corporation Personalized home automation control based on individualized profiling
US10073428B2 (en) 2015-12-31 2018-09-11 Echostar Technologies International Corporation Methods and systems for control of home automation activity based on user characteristics
US10060644B2 (en) 2015-12-31 2018-08-28 Echostar Technologies International Corporation Methods and systems for control of home automation activity based on user preferences
CN106124749B (zh) * 2016-02-26 2019-01-29 深圳市先亚生物科技有限公司 一种红细胞寿命测定方法及装置
US9882736B2 (en) 2016-06-09 2018-01-30 Echostar Technologies International Corporation Remote sound generation for a home automation system
US10294600B2 (en) 2016-08-05 2019-05-21 Echostar Technologies International Corporation Remote detection of washer/dryer operation/fault condition
US10049515B2 (en) 2016-08-24 2018-08-14 Echostar Technologies International Corporation Trusted user identification and management for home automation systems
JP2023527463A (ja) * 2020-05-29 2023-06-28 ベレロフォン・セラピューティクス 気体状薬剤のパルス式送達方法
US11636870B2 (en) 2020-08-20 2023-04-25 Denso International America, Inc. Smoking cessation systems and methods
US11828210B2 (en) 2020-08-20 2023-11-28 Denso International America, Inc. Diagnostic systems and methods of vehicles using olfaction
US12269315B2 (en) 2020-08-20 2025-04-08 Denso International America, Inc. Systems and methods for measuring and managing odor brought into rental vehicles
US12017506B2 (en) 2020-08-20 2024-06-25 Denso International America, Inc. Passenger cabin air control systems and methods
US11760169B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Particulate control systems and methods for olfaction sensors
US12251991B2 (en) 2020-08-20 2025-03-18 Denso International America, Inc. Humidity control for olfaction sensors
US11760170B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Olfaction sensor preservation systems and methods
US11881093B2 (en) 2020-08-20 2024-01-23 Denso International America, Inc. Systems and methods for identifying smoking in vehicles
US12377711B2 (en) 2020-08-20 2025-08-05 Denso International America, Inc. Vehicle feature control systems and methods based on smoking
US11813926B2 (en) 2020-08-20 2023-11-14 Denso International America, Inc. Binding agent and olfaction sensor
US11932080B2 (en) 2020-08-20 2024-03-19 Denso International America, Inc. Diagnostic and recirculation control systems and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005531376A (ja) * 2002-07-04 2005-10-20 イーエンオー セラピューティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング Coの投与方法及び装置
WO2013148232A1 (en) * 2012-03-27 2013-10-03 Genentech, Inc. Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778413B2 (en) * 2010-05-14 2014-07-15 Ikaria, Inc. Dosing regimens and methods of treatment using carbon monoxide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005531376A (ja) * 2002-07-04 2005-10-20 イーエンオー セラピューティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング Coの投与方法及び装置
WO2013148232A1 (en) * 2012-03-27 2013-10-03 Genentech, Inc. Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KOREAN J. INT. MED., vol. 28, no. 2, JPN6018035282, March 2013 (2013-03-01), pages 123 - 140, ISSN: 0004025998 *

Also Published As

Publication number Publication date
US20160256485A1 (en) 2016-09-08
MX2016006252A (es) 2017-02-02
EP3068409A1 (en) 2016-09-21
WO2015073912A1 (en) 2015-05-21
US20190022132A1 (en) 2019-01-24
EP3068409A4 (en) 2017-08-23

Similar Documents

Publication Publication Date Title
JP2016537427A (ja) 一酸化炭素を用いた肺疾患の治療または予防
CN110520043B (zh) 使用呼吸气体样品进行呼吸测量的系统和方法
JP7813138B2 (ja) 肺に関連する状態を有する患者における活動レベルを改善するための一酸化窒素吸入療法(iNO)の使用
Silkoff et al. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma
Gorman et al. Ventilatory physiology of patients with panic disorder
Niesters et al. High-inspired oxygen concentration further impairs opioid-induced respiratory depression
US20230158260A1 (en) Use of inhaled nitric oxide (ino) for the improvement of severe hypoxemia
US11389471B2 (en) Systems and methods to improve organ or tissue function and organ or tissue transplant longevity
Delclaux et al. Factors associated with dyspnea in adult patients with sickle cell disease
Clavieras et al. Prospective randomized crossover study of a new closed-loop control system versus pressure support during weaning from mechanical ventilation
Hopkins et al. Effects of inhaled nitric oxide on gas exchange in lungs with shunt or poorly ventilated areas
Cockcroft et al. Volume adjustment of maximal midexpiratory flow: importance of changes in total lung capacity
Lam et al. The selective pulmonary vasodilatory effect of inhaled DETA/NO, a novel nitric oxide donor, in ARDS—a pilot human trial
Ohkura et al. Evaluation of airway hyperresponsiveness and exhaled nitric oxide as risk factors for airway remodeling in patients with stable asthma
Zavorsky et al. Acute hypervolaemia improves arterial oxygen pressure in athletes with exercise-induced hypoxaemia
Blaisdell et al. Pulmonary function testing
Vermeulen et al. Predictive performance of a physiological model for enflurane closed‐circuit anaesthesia: effects of continuous cardiac output measurements and age‐related solubility data
Sullivan et al. Lung mechanics and neuromuscular output during CO2 inhalation after airway anesthesia
Huang et al. Intrabreath analysis of carbon monoxide uptake during exercise in patients at risk for lung injury
Nordin et al. Is lung diffusing capacity lower in expiratory flow limited women compared to non-flow limited women during exercise?
Zelter et al. Assessment of Lung Physiology Using Pulmonary Function Tests

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171114

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171114

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180907

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181203

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190426